SUZANNE GIRARD: Open Payments
NPI 1578196770 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 21 payments from 12 companies in 2025. Trend: 2023 $37 · 2024 $279 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: INGREZZA, VRAYLAR, ARISTADA, INVEGA SUSTENNA, Wegovy, AUSTEDO XR, Veozah, Cologuard Collection Kit.
Industry payments across WI — which companies pay providers there.
